A Randomized, Double-Blind, Placebo Controlled, Fixed Do

Project: Research project

Project Details

Description

A Randomized, Double-Blind, Placebo Controlled, Fixed Dose Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia (SD-809-C-23)
StatusFinished
Effective start/end date11/1/1410/31/15

Funding

  • AUSPEX PHARMACEUTICALS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.